ACULAR PRESERVATIVE FREE
LOE ApproachingNDAOPHTHALMICSOLUTION/DROPS
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ACULAR PRESERVATIVE FREE is a small-molecule ophthalmic solution approved in 1997 for use in eye care. The preservative-free formulation is designed for patients requiring topical ocular therapy without exposure to preservative agents. Specific indications and mechanism of action are not detailed in available data.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30%), signaling reduced team expansion and emphasis on efficiency and market defense.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings reflect the product's mature lifecycle stage and approaching LOE, indicating limited hiring and team growth. Roles on this product focus on defending market share and managing competitive and generic erosion rather than expansion.
Brand ManagerField Sales Representative
Worked on ACULAR PRESERVATIVE FREE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.